EGFR and malignant colon neoplasm: Thiosemicarbazones have been reported to downregulate EGFR expression and phosphorylation in pancreatic and colon cancer cells (Kovacevic et al., 2016); however, we did not detect any alterations in EGFR activity after treatment with DpC.